Prognostic value of PANOMEN-3 classification for hypopituitarism in surgically and nonoperatively managed pituitary adenomas
Endocrine Connections · 01.03.2026 · 15 (3)
DOI: 10.1530/ec-26-0123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 11.03.2026. Verfasst von Afif Nakhleh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The prognostic value of Pituitary Adenoma Nomenclature 3 (PANOMEN-3) for incident or persistent hypopituitarism remains uncertain. This study aimed to assess whether baseline PANOMEN-3 grade and its components predict secondary adrenal insufficiency or secondary hypothyroidism in surgically and nonoperatively managed patients.
Methods
We conducted a retrospective cohort study of adults with newly diagnosed pituitary adenoma at Rambam Health Care Campus, a tertiary referral center in Haifa, Israel, between 2010 and 2023. Follow-up was censored on August 31, 2025. Patients were stratified by management (surgical or nonoperative). PANOMEN-3 grades were assigned at the index visit, defined as the initial endocrinology consultation. The primary outcome was the incidence of the composite of secondary adrenal insufficiency or secondary hypothyroidism at follow-up.
Results
The study included 208 adults with pituitary adenomas: 118 underwent transsphenoidal surgery and 90 were managed nonoperatively. In the surgical group, the incidence of secondary adrenal insufficiency or secondary hypothyroidism at a median follow-up of 17.4 months (IQR: 5.0–47.7) was 32.2% and increased with higher baseline PANOMEN-3 grade (0% in grade 0 to 61.1% in grade 3; P = 0.01). In the nonoperative group, the incidence was 11.1% at a median follow-up of 15.5 months (IQR: 5.7–35.8) and was likewise associated with higher baseline grade (0% in grade 0 to 20.0% in grade 3; P = 0.02). Across both groups, baseline hypopituitarism and larger adenoma size were associated with secondary adrenal insufficiency or secondary hypothyroidism (surgical: P < 0.001 and P = 0.04; nonoperative: P < 0.001 and P = 0.03).
Conclusion
PANOMEN-3 grading effectively stratifies the risk of secondary adrenal and thyroid dysfunction in both surgical and nonoperative settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel.
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
- Department of Neurosurgery, Rambam Health Care Campus, Haifa, Israel.
- Ruth & Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
Zitieren
APA
Nakhleh, A., Ayada, G., Assalia Naffa, M., Sviri, G., & Zolotov, S. (2026). Prognostic value of PANOMEN-3 classification for hypopituitarism in surgically and nonoperatively managed pituitary adenomas. Endocrine Connections, 15(3). https://doi.org/10.1530/ec-26-0123
Vancouver
Nakhleh A, Ayada G, Assalia Naffa M, Sviri G, Zolotov S. Prognostic value of PANOMEN-3 classification for hypopituitarism in surgically and nonoperatively managed pituitary adenomas. Endocrine Connections. 2026;15(3). doi:10.1530/ec-26-0123
BibTeX
@article{Nakhleh2026,
author = {Nakhleh, Afif and Ayada, Gida and Assalia Naffa, Mai and Sviri, Gill and Zolotov, Sagit},
title = {Prognostic value of PANOMEN-3 classification for hypopituitarism in surgically and nonoperatively managed pituitary adenomas},
journal = {Endocrine Connections},
year = {2026},
volume = {15},
number = {3},
doi = {10.1530/ec-26-0123}
}
EUVIMED